Correlation Between 23Andme Holding and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Rani Therapeutics Holdings, you can compare the effects of market volatilities on 23Andme Holding and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Rani Therapeutics.
Diversification Opportunities for 23Andme Holding and Rani Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Rani is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Rani Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Rani Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 0.74 times more return on investment than Rani Therapeutics. However, 23Andme Holding Co is 1.36 times less risky than Rani Therapeutics. It trades about -0.06 of its potential returns per unit of risk. Rani Therapeutics Holdings is currently generating about -0.05 per unit of risk. If you would invest 602.00 in 23Andme Holding Co on November 2, 2024 and sell it today you would lose (261.00) from holding 23Andme Holding Co or give up 43.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| 23Andme Holding |
| Rani Therapeutics |
23Andme Holding and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Rani Therapeutics
The main advantage of trading using opposite 23Andme Holding and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Rani Therapeutics vs. Vincerx Pharma | Rani Therapeutics vs. Tenaya Therapeutics | Rani Therapeutics vs. Corvus Pharmaceuticals | Rani Therapeutics vs. Alx Oncology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |